- Home
- OSUR vs UROY Comparison
OSUR vs UROY Comparison
Compare OSUR & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- UROY
- Stock Information
- Founded
- OSUR 2000
- UROY 2017
- Country
- OSUR United States
- UROY Canada
- Employees
- OSUR N/A
- UROY N/A
- Industry
- OSUR Medical/Dental Instruments
- UROY
- Sector
- OSUR Health Care
- UROY
- Exchange
- OSUR Nasdaq
- UROY Nasdaq
- Market Cap
- OSUR 248.3M
- UROY 239.1M
- IPO Year
- OSUR 1986
- UROY N/A
- Fundamental
- Price
- OSUR $3.37
- UROY $1.82
- Analyst Decision
- OSUR Hold
- UROY Strong Buy
- Analyst Count
- OSUR 2
- UROY 2
- Target Price
- OSUR $5.50
- UROY $5.60
- AVG Volume (30 Days)
- OSUR 699.3K
- UROY 2.6M
- Earning Date
- OSUR 05-07-2025
- UROY 03-06-2025
- Dividend Yield
- OSUR N/A
- UROY N/A
- EPS Growth
- OSUR N/A
- UROY N/A
- EPS
- OSUR N/A
- UROY N/A
- Revenue
- OSUR $185,827,000.00
- UROY $15,984,827.00
- Revenue This Year
- OSUR N/A
- UROY N/A
- Revenue Next Year
- OSUR $7.46
- UROY $6.55
- P/E Ratio
- OSUR N/A
- UROY N/A
- Revenue Growth
- OSUR N/A
- UROY N/A
- 52 Week Low
- OSUR $2.69
- UROY $1.57
- 52 Week High
- OSUR $6.35
- UROY $3.12
- Technical
- Relative Strength Index (RSI)
- OSUR 45.10
- UROY 43.69
- Support Level
- OSUR $3.34
- UROY $1.72
- Resistance Level
- OSUR $3.56
- UROY $1.95
- Average True Range (ATR)
- OSUR 0.15
- UROY 0.08
- MACD
- OSUR -0.00
- UROY 0.01
- Stochastic Oscillator
- OSUR 10.53
- UROY 35.09
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
About UROY Uranium Royalty Corp.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is the investment in a portfolio of uranium interests.